FR2878160B1 - USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY - Google Patents

USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY

Info

Publication number
FR2878160B1
FR2878160B1 FR0412292A FR0412292A FR2878160B1 FR 2878160 B1 FR2878160 B1 FR 2878160B1 FR 0412292 A FR0412292 A FR 0412292A FR 0412292 A FR0412292 A FR 0412292A FR 2878160 B1 FR2878160 B1 FR 2878160B1
Authority
FR
France
Prior art keywords
hypersensiblity
photic
magnesium
preparation
inhibitory drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0412292A
Other languages
French (fr)
Other versions
FR2878160A1 (en
Inventor
Jean Pierre Durlach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0412292A priority Critical patent/FR2878160B1/en
Publication of FR2878160A1 publication Critical patent/FR2878160A1/en
Application granted granted Critical
Publication of FR2878160B1 publication Critical patent/FR2878160B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
FR0412292A 2004-11-19 2004-11-19 USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY Active FR2878160B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0412292A FR2878160B1 (en) 2004-11-19 2004-11-19 USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412292A FR2878160B1 (en) 2004-11-19 2004-11-19 USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY

Publications (2)

Publication Number Publication Date
FR2878160A1 FR2878160A1 (en) 2006-05-26
FR2878160B1 true FR2878160B1 (en) 2008-07-25

Family

ID=34952851

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0412292A Active FR2878160B1 (en) 2004-11-19 2004-11-19 USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY

Country Status (1)

Country Link
FR (1) FR2878160B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1025645B1 (en) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis COMPOUND FOR THE TREATMENT OF NEUROTOXICITY DUE TO HYPEREXCITABILITY OF IOTOTROPIC GLUTAMATERGIC RECEPTORS
WO2022264167A1 (en) * 2021-06-15 2022-12-22 Celagenex Research (India) Pvt. Ltd. A synergistic composition for inhibiting vascular calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (en) * 1977-03-23 1978-10-20 Francaise Coop Pharma NEW DERIVATIVES OF TAURINE WITH ENHANCED NEUROMUSCULAR ACTIVITY
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples

Also Published As

Publication number Publication date
FR2878160A1 (en) 2006-05-26

Similar Documents

Publication Publication Date Title
FR15C0046I2 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
FR13C0029I2 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
IS8197A (en) Multilayer oral solution tablet
FR2854074B1 (en) USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
FR2879914B1 (en) INTESTINAL RETRACTOR RETRACTOR FOR COELIOSCOPIC SURGERY
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
FR2873294B1 (en) ASSOCIATION OF DRUGS
FR2873926B1 (en) COMPOSITION FOR REDUCING BLOOD LIPIDS
FR2878160B1 (en) USE OF MAGNESIUM N-ACETYL TAURINATE FOR THE PREPARATION OF INHIBITORY DRUGS FOR PHOTIC HYPERSENSIBLITY
PL1637165T3 (en) Medicinal cooling emulsions
FR2883180B1 (en) USE OF ACETYL LEUCINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF BALANCE DISORDERS
MA28513B1 (en) PROCESS FOR THE PREPARATION OF TRYPTASE INHIBITORS
FR2896690B1 (en) USE OF MEQUITAZINE ENANTIOMER (S) FOR THE PREPARATION OF A MEDICINAL PRODUCT WHILE LIMITING GENOMIC TOXICITY
FR2837707B1 (en) USE OF 8'-HYDROXYDIHYDROERGOTAMINE FOR AN ANXIOLYTIC DRUG
FR2866570B1 (en) USE OF THE METRONIDAZOLE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING SKIN INFLAMMATION
FR2881655B3 (en) PREPARATION OF ALDESLEUKINE FOR PHARMACEUTICAL USE
FR2908652B1 (en) USE OF ETHOXUQUINE FOR THE TREATMENT OF CANITIA
FR2866568B1 (en) USE OF THE METRONIDAZOLE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TREATING A DISORDER OF SKIN VASCULARIZATION
UA10726S (en) SET OF PACKAGING FOR THE PHARMACEUTICAL PREPARATION "DERMAZOL"
ITSV20040008A1 (en) DOCTOR "G"
FR2862313B1 (en) NEW MEANS FOR THE PREVENTION OF LEISHMANIOSES
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19